Evidence map›Paper›PMID 40734698›Full record

ArticlePublic health challenges2025

In Vitro Fertilization in Africa: Mild Versus Conventional Antagonist Ovarian Stimulation Protocols in Expected Normal Responders Undergoing IVF/ICSI: A Cohort Study From Ethiopia.

Mekia Kedir, Mustafa Negash, Abel Teshome, Abraham Fessehaye Sium

Abstract read
In one paragraph

Article in Public health challenges, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mekia KedirDepartment of Obstetrics and Gynecology St. Paul's Hospital Millennium Medical College (SPHMMC) Addis Ababa Ethiopia.
Mustafa NegashDepartment of Obstetrics and Gynecology St. Paul's Hospital Millennium Medical College (SPHMMC) Addis Ababa Ethiopia.
Abel TeshomeDepartment of Obstetrics and Gynecology St. Paul's Hospital Millennium Medical College (SPHMMC) Addis Ababa Ethiopia.
Abraham Fessehaye SiumDepartment of Obstetrics and Gynecology St. Paul's Hospital Millennium Medical College (SPHMMC) Addis Ababa Ethiopia.ORCID https://orcid.org/0000-0001-5812-0804

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Though infertility remains a global public health problem, it stands as a unique challenge in Sub-Saharan Africa, with either no or limited in vitro fertilization (IVF) service in most countries located in it. This study aimed to compare the efficacy of mild stimulation with conventional GnRH antagonist ovarian stimulation in patients with expected normal responders at a public IVF center in Ethiopia. Methods: A retrospective cohort study was conducted at Center for Fertility and Reproductive Medicine in Ethiopia. The primary outcomes were biochemical pregnancy rate, clinical pregnancy rate, and mature (M2) oocyte retrieval rate. Data were collected retrospectively by reviewing medical records of patients. SPSS version 26 was used to analyze the data. Mann-Whitney Results: Five hundred infertile women (age ≤39) undergoing their first IVF cycle. A total of 150 women exposed to mild stimulation group and 350 women exposed to conventional or antagonist IVF-group). The biochemical pregnancy was higher in MS-IVF, which is 35.3% and 28.6% in conventional (antagonist) IVF group, Conclusions: Compared to conventional antagonist IVF, MS-IVF has a higher biochemical pregnancy and lower risk of multiple pregnancy with comparative rates of clinical pregnancy, OHSS, and mature oocyte (M2).

Indexed as

ARTin vitro fertilization (IVF)low‐middle incomeovarian stimulationSub‐Saharan

Identifiers

PMID40734698
PMCPMC12304084

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.